An internet-based intervention augmented with a diet and physical activity consultation to decrease the risk of dementia in at-risk adults in a primary care setting: pragmatic randomized controlled trial by Anstey, KJ et al.
Original Paper
An Internet-Based Intervention Augmented With a Diet and
Physical Activity Consultation to Decrease the Risk of Dementia
in At-Risk Adults in a Primary Care Setting: Pragmatic Randomized
Controlled Trial
Kaarin J Anstey1,2,3, PhD; Nicolas Cherbuin3, PhD; Sarang Kim4, PhD; Mitchell McMaster3, BSc; Catherine D'Este5,6,
PhD; Nicola Lautenschlager7, PhD, MD; George Rebok8, PhD; Ian McRae3, PhD; Susan J Torres9, PhD; Kay L Cox10,
PhD; Constance Dimity Pond11, PhD, MD
1School of Psychology, University of New South Wales, Sydney, Australia
2Neuroscience Research Australia, Sydney, Australia
3Centre for Research on Ageing, Health and Wellbeing, Australian National University, Canberra, Australia
4Wicking Dementia Resaerch & Education Centre, University of Tasmania, Hobart, Australia
5National Centre for Epidemiology and Public Health, Australian National University, Canberra, Australia
6School of Medicine and Public Health, University of Newcastle, Newcastle, Australia
7Academic Unit for Psychiatry of Old Age, University of Melbourne, Melbourne, Australia
8Johns Hopkins Centre on Aging and Health, Johns Hopkins University, Baltimore, MD, United States
9Institute for Physical Activity and Nutrition, School of Exercise and Nutrition Sciences, Deakin University, Melbourne, Australia
10Medical School, University of Western Australia, Perth, Australia
11Department of General Practice, University of Newcastle, Newcastle, Australia
Corresponding Author:
Kaarin J Anstey, PhD
School of Psychology








Background: There is a need to develop interventions to reduce the risk of dementia in the community by addressing lifestyle
factors and chronic diseases over the adult life course.
Objective: This study aims to evaluate a multidomain dementia risk reduction intervention, Body Brain Life in General Practice
(BBL-GP), targeting at-risk adults in primary care.
Methods: A pragmatic, parallel, three-arm randomized trial involving 125 adults aged 18 years or older (86/125, 68.8% female)
with a BMI of ≥25 kg/m2 or a chronic health condition recruited from general practices was conducted. The arms included (1)
BBL-GP, a web-based intervention augmented with an in-person diet and physical activity consultation; (2) a single clinician–led
group, Lifestyle Modification Program (LMP); and (3) a web-based control. The primary outcome was the Australian National
University Alzheimer Disease Risk Index Short Form (ANU-ADRI-SF).
Results: Baseline assessments were conducted on 128 participants. A total of 125 participants were randomized to 3 groups
(BBL-GP=42, LMP=41, and control=42). At immediate, week 18, week 36, and week 62 follow-ups, the completion rates were
43% (18/42), 57% (24/42), 48% (20/42), and 48% (20/42), respectively, for the BBL-GP group; 71% (29/41), 68% (28/41), 68%
(28/41), and 51% (21/41), respectively, for the LMP group; and 62% (26/42), 69% (29/42), 60% (25/42), and 60% (25/42),
respectively, for the control group. The primary outcome of the ANU-ADRI-SF score was lower for the BBL-GP group than the
control group at all follow-ups. These comparisons were all significant at the 5% level for estimates adjusted for baseline differences
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(immediate: difference in means −3.86, 95% CI −6.81 to −0.90, P=.01; week 18: difference in means −4.05, 95% CI −6.81 to
−1.28, P<.001; week 36: difference in means −4.99, 95% CI −8.04 to −1.94, P<.001; and week 62: difference in means −4.62,
95% CI −7.62 to −1.62, P<.001).
Conclusions: A web-based multidomain dementia risk reduction program augmented with allied health consultations administered
within the general practice context can reduce dementia risk exposure for at least 15 months. This study was limited by a small
sample size, and replication on a larger sample with longer follow-up will strengthen the results.
Trial Registration: Australian clinical trials registration number (ACTRN): 12616000868482;
https://anzctr.org.au/ACTRN12616000868482.aspx.
(J Med Internet Res 2020;22(9):e19431) doi: 10.2196/19431
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Introduction
Background
In 2015, it was estimated that approximately 47 million people
were living with dementia, and this number is expected to reach
131 million by 2050 [1]. It is estimated that a 10%-25%
reduction in 7 key risk factors could prevent 1.1 to 3.0 million
cases of dementia worldwide [2,3]. Furthermore, the risk factors
for dementia are shared with risk factors for other chronic
diseases [4]. Interventions that reduce the risk of dementia are
therefore likely to also reduce the risk of other chronic diseases
and promote healthy aging. In relation to cognition, prevention
and delay of cognitive impairment will also benefit individuals
and reduce health service usage [5-7].
To afford a greater chance of producing detectable changes
during study time frames, the dementia research community
has increasingly focused on multidomain interventions that
address multiple risk factors simultaneously [8]. Alzheimer
disease (AD) is the most common cause of dementia. Reviews
of cohort studies have found that a similar set of risk factors is
associated with AD and all-cause dementia [3]. Among
individuals with high risk factor burden, cognitive decline can
be reduced (and possibly reversed) by cardiovascular risk
reduction, by increasing activities that stimulate and protect the
brain, including cognitive [9], social [10], and physical activity
[11], and by an appropriate diet [12,13]. Dementia and
cardiovascular diseases share cardiometabolic and lifestyle risk
factors [4]. Both cardiovascular disease and dementia risk
reduction can be achieved by smoking cessation; increasing
physical activity; adopting a healthy diet; reducing abnormally
high blood pressure and cholesterol in midlife; and managing
major depression, overweight or obesity in midlife, and diabetes
if present [14]. Altogether, the literature supports the view that
multidomain interventions aimed at reducing cardiometabolic
risk and promoting behaviors protective against dementia will
contribute to preventing cognitive decline, reducing the overall
risk of dementia, and lowering depressive symptoms [15,16].
To bring about risk reduction and implement current guidelines
on dementia risk reduction [17], there needs to be long-lasting
behavioral changes in multiple areas. Moreover, strategies are
required to identify adults with risk factors for dementia and to
encourage them to make appropriate lifestyle changes.
Achieving this requires developing pragmatic interventions that
could be implemented in existing health or community settings
[18,19] and using techniques such as goal setting, decreasing
barriers to change, improving self-monitoring, increasing access
to information, and maintaining motivation [20,21]. Therefore,
this randomized controlled trial (RCT) investigated whether
lifestyle management programs that offer not only
health-promoting information but also practical behavior change
techniques that can be implemented in daily life can reduce
dementia risk.
Objectives
Assessment of cardiovascular risk factors is common in primary
care, as is lifestyle advice. General practice is therefore a setting
where the need for dementia risk reduction interventions may
be identified and where interventions may be prescribed [22].
Studies have been conducted in a primary care setting with older
adults to address the management of cardiovascular risk factors
[23,24] to reduce the risk of dementia. However, the current
program is the first of its kind to provide interventions to adults
(aged ≥18 years) in the primary care setting, addressing both
cardiovascular and lifestyle risk factors of dementia.
Specifically, the objectives of this study are to determine, in
community-dwelling adults who are overweight or have chronic
health conditions, the effectiveness of (1) a web-based
multidomain dementia risk reduction intervention (Body Brain
Life in General Practice [BBL-GP]) developed by the authors,
in comparison to (2) a single clinician–led group, Lifestyle
Modification Program (LMP), developed by a general practice
cooperative, and (3) a web-based active control condition
developed by the authors.
Methods
Trial Design
The trial protocol for the BBL-GP study is published elsewhere
[25]. Briefly, it is a three-arm, pragmatic, single-blind RCT to
reduce the risk of cognitive decline in at-risk individuals
attending a general practice. The study was conducted within
the National Health Co-op (NHC), a bulk billing general practice
(ie, patients’ general practitioner [GP] fees are fully funded by
a universal health cover Medicare scheme) in Canberra, with 8
clinics drawn from low- and middle-income areas. Canberra
has a cold climate and a slightly higher than average level of
education compared with the national average in Australia [26].
It also has a lower rate of bulk billing primary care services than
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any other state or territory in Australia [27]. The NHC had an
existing program called the LMP, to which practice physicians
referred patients diagnosed with or at-risk of chronic health
conditions. To integrate the trial into existing referral pathways
at the clinics, the referral criteria for LMP were used as the trial
eligibility criteria, and this was managed by the clinic’s LMP
coordinator.
Participants
Recruitment occurred via email, posters displayed in the NHC
clinics, and the NHC website. Participants who expressed
interest in the study were contacted by the LMP coordinator for
a screening assessment of inclusion and exclusion criteria
(outlined below). After eligible volunteers provided written
informed consent, they were provided log-in details for the
BBL-GP study website for web-based data collection purposes;
a clinic appointment was also organized. Participant recruitment
was undertaken over a 12-month period from mid-July 2016
until the end of July 2017, and the final follow-ups were
completed in December 2018. Appointments were booked by
the NHC staff. The research team was not involved in
recruitment or assessment. The Australian National University
Human Research Ethics Committee approved the study.
Eligibility Criteria
The eligibility criteria included being aged 18 years or older,
being a resident in the Australian Capital Territory or
surroundings, being a registered member of the NHC (which
involves paying a joining fee of AUD $30 [US $21.90] and an
annual fee of AUD $100 [US $73]), having home access to a
computer and internet, having English fluency, having
Australian permanent residency or citizenship (for universal
health cover eligibility), being the sole member of a household
taking part in the study, and having a chronic health condition
that would make the participant eligible for the NHC lifestyle
management program (eg, hypertension, heart disease, type 2
diabetes, osteoporosis, polycystic ovary syndrome, kidney or
liver disease) or being overweight or obese (BMI ≥25 kg/m2).
All participants aged older than 60 years were required to score
within the nonimpaired range on the Mini-Mental State
Examination (MMSE; ≥25) [28] to be enrolled in the study.
Exclusion criteria included significant and unstable medical
and psychiatric conditions precluding participation, sensory
deficits, or mobility limitations that would prevent completion
of the interventions, cognitive impairment (including AD or
dementia), pregnancy, and previous participation in the LMP.
Interventions
The BBL-GP intervention is a 12-week program that includes
(1) 8 web-based electronic learning modules on dementia
literacy, risk factors, physical activity, nutrition, health condition
management, cognitive activity, social activity, and mood and
(2) tailored, face-to-face physical activity and nutrition sessions.
BBL-GP participants were required to complete all 8 modules.
The dementia literacy and risk factor modules were standardized
across participants and were released at the rate of one per week
after completion of the prior module, with the same timing for
all participants. For the remaining modules, the content was
tailored to participants’ individual risk profiles as indicated by
the baseline Australian National University Alzheimer Disease
Risk Index Short Form (ANU-ADRI-SF; described below). The
tailoring algorithms are included in Multimedia Appendix 1.
These modules were also released at the rate of one per week,
which was the same for all participants. The same exercise
physiologist and 3 dietitians conducted all face-to-face sessions
for the BBL-GP participants. The dietitians and exercise
physiologist were all staff members within the NHC, but their
services for this project were funded by a research grant.
Participants at baseline who had unintentional weight loss or
weight gain (±5 kg) or scored low on the Australian
Recommended Food Score were seen by one of the dietitians
(1-hour face-to-face) [25] and reviewed via phone at weeks 4,
12, and 20. Each participant received a single exercise
physiology session that involved an evaluation of their current
exercise level, fitness, and any preexisting health conditions
and the design of a personal exercise program. Although
follow-up via phone was planned, this was not conducted. The
content of the dietitian’s session was dietary education and
advice to assist the participant in adapting their diet to a healthy
diet in areas that were identified as unhealthy in the dietary
questionnaire. Diet and exercise physiologist sessions varied
depending on the participants’ clinical needs and baseline
measures. All sessions related to the BBL-GP were provided
free of charge to the participants.
The LMP intervention was a face-to-face, practice-based,
6-week program provided by the NHC to its members for free.
It included group sessions providing generic information on
basic nutrition, meal planning, physical activity, health
conditions, motivation and goals, medications, and sleep. All
LMP sessions were conducted by an NHC clinical staff member
using existing clinic resources. Each LMP group session
involved up to 20 participants, and relevant sessions were
conducted by one of the 3 dietitians and an exercise physiologist
as for the BBL-GP group.
The 12-week active control arm involved weekly emails sent
to participants that included links to information regarding
lifestyle risk factors and disease management. At the end of the
intervention, participants in the active control group received
a 1-hour, face-to-face, group-based risk reduction workshop
that provided the information contained in the BBL-GP
intervention. This was held at the Australian National University
and involved 1 to 6 participants and was delivered by KA with
assistance from SK and MM.
Participants from all groups were sent a standard email when
they were due for their follow-up appointment (18, 32, and 62
weeks). They were asked to complete their web-based
assessments that were located on the BBL website, plus a diet
quiz for which links were provided. If the web-based follow-up
was not completed after 1 week, participants received a
follow-up phone call from the research team with additional
phone calls to request completion of missing sections of the
assessments. The NHC receptionist arranged follow-up
appointments for clinical assessments. The assessment was
treated as missing after 3 follow-up phone calls. At the
completion of the trial, participants were invited to complete a
feedback questionnaire on the web, which included structured
questions and one open-ended comment.
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Following completion of the baseline assessment, consenting
participants were randomized to one of the 3 intervention groups
in a 1:1:1 ratio, stratified by sex and age group (18-49 vs ≥50
years) using permuted blocks of 6. Randomization was
performed using the Sealed Envelope software [29] by a
researcher not involved in the study, and the allocation sequence
was provided to the project manager, who was also not involved
in conducting assessments. The project manager then assigned
the participant to their intervention group according to the
schedule and notified the participant of their group allocation
via email. Participants were not blinded to the group allocation.
Study conditions were presented as 3 alternative lifestyle
interventions in recruitment materials. Participants were not
informed of the intervention of interest to the researchers.
Web-based research data were stored on a server at the
Australian National University, which was compliant with
Australian data protection laws.
Outcomes
Web-based surveys and face-to-face visits to the NHC were
conducted for the baseline evaluation and for the 18-, 36-, and
62-week follow-ups. Immediate follow-up (at the end of the
formal program) was conducted on the web at week 7 for LMP
and week 13 for the BBL-GP and control groups. These times
were chosen to evaluate the immediate effects and the long-term
effects of the intervention.
The web-based questionnaire included the primary outcome
measure, the ANU-ADRI-SF [30]. The ANU-ADRI-SF is a
shortened version of the ANU-ADRI [31]. Intraclass correlation
coefficients assessing the agreement of individual components
on the original and short-form ANU-ADRI were high
(0.77-0.99). The ANU-ADRI has been externally validated in
3 cohort studies to predict dementia [32] and on a fourth cohort
to predict mild cognitive impairment (MCI) [33]. The
ANU-ADRI-SF questionnaire included secondary outcome
measures of self-reported physical activity using the short
version of the International Physical Activity Questionnaire
(IPAQ) [34]. Additional questionnaires were the Pittsburgh
Sleep Quality Index (PSQI) [35], the 12-item Short-Form Health
Survey (SF-12) [36], and the Australian Recommended Food
Score (ARFS) [37]. The web-based baseline assessment also
included the Multidimensional Health Questionnaire [38] and
the Adult Pre-exercise Screening System (APSS) [39] to identify
individuals with acute or high-risk conditions or those who may
be at higher risk of adverse events during exercise. The results
of the APSS were provided to the exercise physiologist before
the one-to-one exercise session with participants in the BBL-GP
group.
Following completion of the web-based surveys, participants
underwent a series of assessments at one of the 5 NHC clinics.
Participants were assessed on sociodemographic characteristics,
anthropometric measures, smoking status, alcohol consumption,
blood pressure, cholesterol, high-density lipoprotein, blood
glucose, social history (marital status and living arrangements),
recreational activities, medical history, medications, and family
history. From the information collected, the Framingham
cardiovascular disease (CVD) risk score and the Australian
Type 2 Diabetes Risk Assessment Tool risk scores were
calculated. Body fat composition was also measured at the clinic
using a bioelectrical impedance analysis, accounting for age,
sex, height, and weight. Cognitive measures included the Trail
Making Test A and B [40] and the Symbol Digit Modalities
Test [41], which were completed via the BBL website on a
desktop computer while participants were at the clinic in the
presence of a clinic nurse. The assessments were conducted
entirely by practice nurses. The MMSE was administered to
individuals aged 60 years or older at baseline (see the Eligibility
Criteria section). Objective physical activity was measured
using the duration of moderate-to-vigorous physical activity
(MVPA) via an ActiGraph monitor (GT9X Link) worn on the
wrist for 7 days following the participants’ clinic visit. MVPA
was calculated as a continuous measure of activity registering
3 or more metabolic equivalents for 10 min or longer on the
activity monitor. Self-reported physical activity was measured
as part of the ANU-ADRI-SF using IPAQ categories for high,
moderate, and low levels of physical activity, and relevant risk
scores were assigned as part of ANU-ADRI.
Compliance
Compliance was measured by completion of web-based
modules, following recommendations provided by the dietitian
and exercise physiologist, or attendance at LMP group sessions,
where relevant [25].
Harms and Other Adverse Events
Study team members monitored and managed any risks
throughout the trial, including data handling and website access.
Participant Experience and Open-Text Feedback
At the conclusion of study participation, each participant
completed a feedback questionnaire requiring them to rate the
following aspects on a 5-point scale: overall study experience,
perceived relevance of the intervention materials, level of
interest in materials, and perceived repetition of intervention
materials. Participants also rated whether participation was
worthwhile and their perceived effectiveness of the group to
which they were randomized.
Sample Size
We planned to recruit 240 participants to detect a difference in
continuous outcomes between groups of SD of 0.5 based on
ANU-ADRI (medium effect, based on a previous BBL project
[42]), assuming 80% power and a two-tailed 5% significance
level and allowing for 33% attrition over time (based on the
previous LMP programs in the NHC).
Statistical Methods
For each outcome, analysis involved the generation of regression
models (linear regression for continuous outcomes: primary
outcome of ANU-ADRI and secondary outcomes of
standardized cognition score, MVPA per week, ARFS, and
PSQI; negative binomial regression for highly right-skewed
continuous or count data: Center for Epidemiological Studies
Depression Scale [CES-D]; and logistic regression for binary
outcomes: proportion with sufficient physical activity), including
age, sex, outcome at each time point, intervention group, time
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point, and the interaction between the intervention group and
time point. Mixed models were used to adjust for the correlation
of outcome within individuals over time. The interaction term
allowed comparison of outcomes between intervention groups
at each time point, unadjusted (primary estimates) and adjusted
(secondary estimates) for baseline values, using the lincom
command in Stata (StataCorp LLC). For continuous outcomes,
the differences in means between groups (unadjusted and
adjusted for baseline differences in outcome) were obtained
with 95% CIs. For binary outcomes, odds ratios with 95% CIs
were obtained unadjusted for baseline differences, whereas the
adjusted estimates or intervention effect was estimated as the
ratio of odds ratios for the relevant time point and baseline: that
is, the odds ratio at the time point of interest divided by the odds
ratio at baseline, with 95% CIs. Outcomes with 95% CIs (means
for continuous outcomes and proportions for binary outcomes)
were graphed for the intervention group at each time point. A
sensitivity analysis adjusted for (in addition to age and sex)
sufficient physical activity, standardized cognition score, ARFS
(diet), SF-12 Physical Component Score, SF-12 Mental
Component Score, and Framingham CVD risk score at baseline
was undertaken because these variables were considered to be
potentially associated with the outcomes or attrition.
The primary analysis was a complete case analysis [43] for all
outcome measures. The secondary analysis involved multiple
imputations to account for missing data in a full
intention-to-treat analysis. Variables included in the imputation
model were sociodemographic characteristics (age, sex, and
years of education at baseline), intervention group, values of
the outcome at each time point, and baseline values of BMI and
SF-12. Imputation was undertaken for all 3 intervention groups
combined, rather than separately for each group, because of the
small number of observations within each group and the number
of observations with missing data. A total of 50 imputation data
sets were generated, and an overall estimate was obtained
according to the Rules by Rubin [44].
Results
Baseline Characteristics
In total, 125 patients were recruited (42 in the BBL-GP group,
41 in the LMP group, and 42 in the control group). Figure 1
shows the flow of participants through the trial and loss to
follow-up for each of the 3 intervention groups. Overall, 31%
(13/42) individuals in the BBL-GP group, 41% (17/41) in the
LMP group, and 45% (19/42) in the control group provided
data at all 5 time points. Although a smaller number of
participants were recruited than planned, recruitment was
stopped because of funding limitations. The planned intervention
and follow-up durations did not change. A total of 66 individuals
provided data at week 62 (20 in the BBL-GP group, 21 in the
LMP group, and 25 in the control group). Baseline
characteristics and outcomes at baseline are shown for the 3
intervention groups in Table 1. The 3 groups were generally
well-matched, although the control group appeared to have a
slightly lower BMI and ANU-ADRI-SF score and slightly higher
scores on CES-D and the BBL-GP group had slightly more
minutes of MVPA per week.
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Figure 1. Participant flow through the trial, follow-up, and analysis. BBL-GP: Body Brain Life in General Practice; LMP: Lifestyle Modification
Program; NHC: National Health Co-op.
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Table 1. Baseline characteristics by intervention group.





NaValues, meanb (SD) or
n (%)
NaValues, meanb (SD) or
n (%)
Na
31 (74%)4227 (66%)4128 (67%)42Female
49.95 (14.03)4251.41 (11.69)4151.14 (14.24)42Age, years
16.11 (4.16)4216.41 (4.25)4115.51 (4.49)42Education, years
32.91 (7.36)4234.55 (6.65)4134.52 (7.11)42BMI, kg/m2
1.82 (6.36)383.11 (7.19)373.22 (7.13)37Australian National University Alzheimer Disease
Risk Index Short Form
0.07 (0.94)410.03 (1.06)37−0.1 (1.01)41Cognition z score
892.51 (420.01)37868.31 (409.62)361041.78 (528.97)40Total MVPAc per weekd
20 (53%)3820 (54%)3719 (51%)37Sufficient physical activity
10 (4,14)427 (3,15)417 (4,15)42Center for Epidemiological Studies Depression Scale
score
36 (8.36)4035.92 (10.42)3835.86 (8.84)42Diet (Australian Recommended Food Score)
8.02 (4.03)417.46 (4.27)416.63 (3.67)41Sleep (Pittsburgh Sleep Quality Index)
44.62 (7.93)4247.12 (10.49)3945.21 (8.62)4212-item Short-Form Health Survey Physical Compo-
nent Score
42.81 (11.10)4245.42 (11.74)3944.95 (11.26)4212-item Short-Form Health Survey Mental Compo-
nent Score
16.3 (5.56)4016.92 (5.66)3815.88 (6.53)40Diabetes risk (Australian Type 2 Diabetes Risk As-
sessment Tool)
3.0 (0,6)343.0 (1,7)353.5 (0,7)38Framingham cardiovascular disease risk score
aNumbers may not add to the total sample size because of missing values.
bMedian (Q1 and Q3) presented for the Center for Epidemiological Studies Depression Scale and Framingham cardiovascular disease risk scores.
cMVPA: moderate-to-vigorous physical activity.
dTotal minutes of MVPA per week (activity registering 3 or more metabolic equivalents for at least 10 min).
Completion Rates and Missing Data
Multimedia Appendix 2 shows the characteristics of individuals
who did (completers) and did not (noncompleters) provide data
at all 5 time points. Although there were no statistically
significant differences between completers and noncompleters,
the sample size was small, and thus, statistical power was low
for these comparisons. Some individuals did not provide
information on the number of hours of each type of physical
activity undertaken, resulting in missing data for both the IPAQ
measure and the overall ANU-ADRI score.
Intervention Effects
Figures 2 to 8 and Multimedia Appendix 3 show the results of
the comparison of outcomes between groups at each follow-up
time from the models adjusted for age and sex. The interaction
terms were statistically significant for the ANU-ADRI-SF and
the PSQI, indicating significant group differences over time.
However, there was only a clear and consistent pattern of better
outcomes over time associated with the interventions for the
primary outcome, ANU-ADRI-SF. This shows that the BBL-GP
intervention reduced the risk of dementia. The difference
between BBL-GP and the control group was only statistically
significant at the 10% level for weeks 36 and 62 for
ANU-ADRI-SF, although the trend for reduced risk scores
remained (immediate: difference in means −2.30, 95% CI −5.93
to 1.34, P=.22; week 18: difference in means −2.49, 95% CI
−5.99 to 1.02, P=.16; week 36: difference in means −3.43, 95%
CI −7.16 to 0.29, P=.07; week 62: difference in means −3.06,
95% CI −6.71 to 0.60, P=.10). After adjusting for baseline
differences in outcomes, in addition to age and sex, the
differences in mean ANU-ADRI-SF between the BBL-GP and
control groups increased (Multimedia Appendix 4) and were
statistically significant at the 5% level at each follow-up time
(immediate: difference in means −3.86, 95% CI −6.81 to −0.90,
P=.01; week 18: difference in means −4.05, 95% CI −6.81 to
−1.28, P<.001; week 36: difference in means −4.99, 95% CI
−8.04 to −1.94, P<.001; week 62: difference in means −4.62,
95% CI −7.62 to −1.62, P<.001). Although the graph of mean
diet score demonstrated some indication of higher scores for
BBL-GP relative to the other group, this was not statistically
significant, possibly because of low power.
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Figure 2. Mean Australian National University Alzheimer Disease Risk Index Short Form with 95% CI, by time point and intervention group.
ANU-ADRI-SF: Australian National University Alzheimer Disease Risk Index Short Form; BBL-GP: Body Brain Life in General Practice; LMP:
Lifestyle Modification Program.
Figure 3. Mean standardized cognition score with 95% CI, by time point and intervention group. BBL-GP: Body Brain Life in General Practice; LMP:
Lifestyle Modification Program.
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Figure 4. Mean moderate-to-vigorous physical activity with 95% CI, by time point and intervention group. BBL-GP: Body Brain Life in General
Practice; LMP: Lifestyle Modification Program; MVPA: moderate-to-vigorous physical activity.
Figure 5. Proportion with sufficient physical activity with 95% CI, by time point and intervention group. Although the upper limit of some 95% CIs
has been estimated as >1, it is not possible for a proportion to exceed 1. BBL-GP: Body Brain Life in General Practice; LMP: Lifestyle Modification
Program; PA: physical activity.
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Figure 6. Mean Center for Epidemiological Studies Depression Scale with 95% CI, by time point and intervention group. BBL-GP: Body Brain Life
in General Practice; CES-D: Center for Epidemiological Studies Depression Scale; LMP: Lifestyle Modification Program.
Figure 7. Mean Diet Score (ARFS) with 95% CI, by time point and intervention group. ARFS: Australian Recommended Food Score; BBL-GP: Body
Brain Life in General Practice; LMP: Lifestyle Modification Program; PSQI: Pittsburgh Sleep Quality Index.
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Figure 8. Mean Sleep Score (PSQI) with 95% CI, by time point and intervention group. BBL-GP: Body Brain Life in General Practice; LMP: Lifestyle
Modification Program.
Sensitivity or Secondary Analyses
Sensitivity analyses adjusted for baseline physical activity,
cognition, diet, mental and physical health, and CVD risk and
secondary analyses using multiple imputation produced results
that were broadly consistent with the primary analyses (although
it was not possible to undertake multiple imputations for all
secondary outcomes because of the lack of convergence of
imputation and/or analysis models).
Compliance
Although adjustment for adherence (compliance) was originally
planned [25], compliance was not considered in the analyses
because of the smaller-than-anticipated number of individuals
recruited and the amount of loss to follow-up.
Harms and Other Adverse Events
No adverse events were reported. There were no privacy
breaches and no major technical problems. Occasional issues
with accessing the website were reported and dealt with by the
study team.
Participant Experience and Open-Text Feedback
A summary of the participant feedback on their experience of
the intervention is found in Multimedia Appendix 5. A total of
21/29 (72.4%) participants who provided feedback rated their
study experience as good or very good, and 20/26 (77%) felt
their participation was worthwhile.
Discussion
Principal Findings
Our study aimed to evaluate the effectiveness of a multidomain
lifestyle intervention in primary care to reduce the risk of
dementia compared with a lifestyle management program that
was already offered to primary care patients and an internet
control condition. The significant group-by-time interaction in
our main analysis showed that the multidomain BBL-GP
lifestyle intervention was effective in reducing the risk of
dementia for a period of at least 15 months. This builds on a
growing body of research supporting the benefits of multidomain
interventions that focus specifically on factors impacting brain
health [8,45]. In contrast, a more generic healthy lifestyle
management program that was not personalized did not result
in dementia risk reduction. Population-based research has shown
that participants aged 60 to 64 years with a one-point lower
ANU-ADRI at baseline have an 8% lower chance of developing
MCI or dementia [33,46] over a 12-year period. Our intervention
achieved a lower ANU-ADRI-SF score of 4.62 (0.62 SD or
equivalent to approximately 2 risk factors) at 62 weeks for the
BBL-GP group relative to the control group in our analyses,
which adjusted for baseline differences in the ANU-ADRI-SF.
We therefore infer that maintenance of these benefits would
translate into a significant shift in the risk of dementia at the
population level, even if the effect size reduced over time.
Limitations and Strengths
Our study had a number of limitations. It was underpowered
because of the smaller-than-anticipated sample and the
pragmatic design whereby all the assessments and follow-ups
were arranged by the NHC staff who assisted with the trial in
addition to their usual workloads. This limited our capacity to
evaluate the secondary outcomes. The sample attrition was
relatively high with regard to attendance at follow-up
appointments. We hypothesize that this was partly because of
the limited role of the research team in arranging appointments
for participants. The study was not resourced for vigilant
follow-up of participants, which differs from our previous trial
where a research assistant undertook this role [47]. This study
utilized the desired model of the NHC and provided a seamless
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patient experience, including the use of NHC staff in their usual
locations conducting assessments. Future research is needed to
develop mechanisms to increase participant follow-up
compliance, co-designed with the general practice. In addition,
more evidence is required to inform the design of interventions
with regard to the number of allied health sessions and the
efficacy of using web-based video to administer these sessions.
A further study limitation was the relatively short length of
follow-up.
The strengths of our study are that the trial was designed in
partnership with a large primary care provider using the practice
staff, space, and booking systems so that patients from the
practice could complete the intervention within their usual
settings. It was also implemented by the clinical staff without
research training, which is more realistic than most research
studies. It is therefore generalizable to the wider primary care
setting in Australia. Our study also included 2 comparison
conditions, including a lifestyle intervention that is used in
clinical practice. Although it was an RCT, the study was
implemented in such a way that the practice could continue the
program if the BBL-GP site and allied health sessions could be
supported and funded. Hence, we were able to demonstrate the
benefits of a dementia-specific, multidomain lifestyle
intervention. Our outcome measure, being a composite
assessment, was sensitive to multidomain risk reduction.
Implications and Conclusions
This trial has several practical implications. The approach to
patient selection was straightforward and compatible with usual
care. GPs only need to identify patients who have a chronic
condition and are appropriate for a lifestyle intervention to select
those who will also benefit from a dementia risk reduction
intervention. Participants were able to participate in the
web-based component of the intervention in their own time and
at minimum cost. The use of specialist practitioners to deliver
the physical activity and nutrition sessions meant that these
were tailored to the individual’s clinical profile. This enabled
broad inclusion criteria because the clinical risk was managed
appropriately. Often, patients with multiple chronic conditions
are excluded from trials, which reduces the ecological validity
and generalizability of findings to the wider population. We
conclude that dementia risk reduction in an adult population is
feasible in the primary care setting and worthy of further
research to establish scalable and sustainable models.
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